Vista AI, Inc. of Palo Alto, US develops AI-based MRI applications to help diagnose cardiovascular disease.
Founded in 2012 and based in California, US, Vista AI, Inc. develops artificial intelligence based magnetic resonance imaging applications and development solutions to aid in the diagnosis of patients with cardiovascular disease. In January 2026, it raised USD 29.5 million in Series B funding from Cedars-Sinai Health System, Intermountain Health, University of Utah Hospital System, Fox Chase Cancer Center and TGH Ventures, with participation from Khosla Ventures and Bold Brain Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in